EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 120 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 4.58 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $3,430,000 | +35.7% | 43,233 | +19.7% | 0.00% | +33.3% |
Q3 2016 | $2,528,000 | +99.5% | 36,109 | +10.5% | 0.00% | +50.0% |
Q2 2016 | $1,267,000 | +7.4% | 32,675 | +12.2% | 0.00% | 0.0% |
Q1 2016 | $1,180,000 | -53.8% | 29,127 | +1.0% | 0.00% | -33.3% |
Q4 2015 | $2,556,000 | +19.8% | 28,828 | +0.0% | 0.00% | 0.0% |
Q3 2015 | $2,133,000 | -9.9% | 28,816 | -1.6% | 0.00% | 0.0% |
Q2 2015 | $2,368,000 | +9007.7% | 29,280 | +4692.1% | 0.00% | – |
Q1 2015 | $26,000 | +188.9% | 611 | +1.7% | 0.00% | – |
Q4 2014 | $9,000 | +12.5% | 601 | 0.0% | 0.00% | – |
Q3 2014 | $8,000 | -11.1% | 601 | 0.0% | 0.00% | – |
Q2 2014 | $9,000 | -91.8% | 601 | -93.0% | 0.00% | – |
Q1 2014 | $110,000 | – | 8,639 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JW Asset Management, LLC | 475,755 | $25,068,000 | 24.71% |
Hudson Executive Capital LP | 971,000 | $51,162,000 | 15.09% |
Park West Asset Management LLC | 1,051,274 | $55,392,000 | 2.47% |
U S GLOBAL INVESTORS INC | 19,200 | $1,012,000 | 0.62% |
Capital Impact Advisors, LLC | 26,317 | $1,387,000 | 0.57% |
CLARK ESTATES INC/NY | 56,278 | $2,965,000 | 0.47% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 873,131 | $46,005,000 | 0.41% |
ProQuest Associates IV LLC | 6,777 | $357,000 | 0.41% |
Granite Investment Partners, LLC | 114,207 | $6,017,000 | 0.40% |
GLOBEFLEX CAPITAL L P | 30,900 | $1,628,000 | 0.34% |